Joseph R. Young
SVP, FINANCE, CHIEF ACCT OFFCR · Vera Therapeutics, Inc.
- 2025
- Sep 14, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Joseph R. Young files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marshall Fordyce - $7.10M in VERA purchases and sales in the last 12 months
- William D. Turner - $1.45M in VERA purchases and sales in the last 12 months
- Sean Grant - $208K in VERA purchases and sales in the last 12 months
- David Lee Johnson - $108K in VERA purchases and sales in the last 12 months
- Jason S. Carter - $107K in VERA purchases and sales in the last 12 months
- Robert Brenner - $90K in VERA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joseph R. Young?
Joseph R. Young is a corporate insider, tracked as SVP, FINANCE, CHIEF ACCT OFFCR of Vera Therapeutics, Inc. (VERA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Joseph R. Young submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Joseph R. Young been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($567K) across all tracked filings.
